(Q40827249)

24 September 2017

Hyperinsulinism and sex hormones in young adult African Americans (English)

1 reference

24 September 2017

Falkner B

1

1 reference

24 September 2017

Sherif K

series ordinal

2

1 reference

24 September 2017

Sumner A

series ordinal

3

1 reference

24 September 2017

Kushner H

series ordinal

4

1 reference

24 September 2017

1 January 1999

1 reference

24 September 2017

6

1 reference

based on heuristic

inferred from page(s)

published in

Metabolism

1 reference

24 September 2017

48

1 reference

24 September 2017

1

1 reference

24 September 2017

107-112

1 reference

Banting lecture 1988. Role of insulin resistance in human disease

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990018-5

Endogenous sex hormones: impact on lipids, lipoproteins, and insulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990018-5

Association of decreased sex hormone binding globulin and cardiovascular risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990018-5

Relationship of sex hormone-binding globulin to lipid, lipoprotein, glucose, and insulin concentrations in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990018-5

Marked hyperinsulinaemia in postmenopausal, healthy Indian (Asian) women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990018-5

Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990018-5

Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990018-5

A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990018-5

The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990018-5

Diet-induced changes in sex hormone binding globulin and free testosterone in women with normal or polycystic ovaries: correlation with serum insulin and insulin-like growth factor-I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990018-5

Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990018-5

Special issues regarding obesity in minority populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990018-5

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990018-5

Insulin Sensitivity, Lipids, and Blood Pressure in Young American Blacks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990018-5

Sex hormone-binding globulin and insulin resistance in African-American women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990018-5

The relationship of sex hormones to hyperinsulinemia and hyperglycemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990018-5

Androgen activity as a risk factor for impaired glucose tolerance in postmenopausal women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990018-5

Steroidal and non-steroidal factors in plasma sex hormone binding globulin regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990018-5

Variation with age in the levels of sex-steroid-binding plasma protein as determined by radioimmunoassay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990018-5

Sex hormone-binding globulin and female reproductive function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990018-5

Insulin resistance in nonobese patients with polycystic ovarian disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990018-5

Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990018-5

Metabolic regulation of androgen production by human thecal cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990018-5

Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990018-5

Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990018-5

10.1016/S0026-0495(99)90018-5

7 January 2021

Identifiers

DOI

1 reference

24 September 2017

1 reference